| Location: | Federal |
|---|---|
| Posted: | Dec 23, 2024 |
| Due: | Jan 24, 2025 |
| Agency: | DEPT OF DEFENSE |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | SPE2D2-24-R-0016 |
| Publication URL: | To access bid details, please log in. |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
The Defense Logistics Agency is issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.
DESCRIPTION EST QTY (YR)
Bicalutamide 50 MG Tablet – 30 Count 23,529
Bicalutamide 50 MG Tablet – 500 Count 1961
This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
| Oct 29, 2024 | [Presolicitation (Original)] Bicalutamide 50MG tablets |
| Jan 27, 2025 | [Solicitation (Updated)] Amendment 0001 Bicalutamide 50MG & 500MG tablets |
| Feb 4, 2025 | [Solicitation (Updated)] Amendment 0003 Bicalutamide 50MG & 500MG tablets |
| Jul 10, 2025 | [Solicitation (Updated)] Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED |

With GovernmentContracts, you can:
Follow Climate Controlled Storage Facility Active Contract Opportunity Notice ID W9126G26RA019 Related Notice
DEPT OF DEFENSE
Bid Due: 6/22/2026
Follow 47--CONNECTION,FLEXIBLE Active Contract Opportunity Notice ID N0010426QYA7W Related Notice Department/Ind. Agency DEPT
DEPT OF DEFENSE
Bid Due: 6/10/2026
Follow Defense Health Agency (DHA) Enterprise Referral Care Coordination Center (RC3) Virtual Industry
DEPT OF DEFENSE
Bid Due: 6/12/2026
Follow ASSY; FIN DRIVE AFT Active Contract Opportunity Notice ID SPRMM126QGC70 Related Notice
DEPT OF DEFENSE
Bid Due: 6/15/2026